Compartmentalization of the IgG immune response to HIV-1 in breast milk

AIDS

Volumn 13, Issue 11, 1999, Pages 1323-1331

  Becquart, Pierre ^a   Hocini, Hakim ^a,b   Garin, Benoît ^a,b,c   Sepou, Abdoulaye ^a,b,c,d   Kazatchkine, Michel D ^a,b,c   Bélec, Laurent ^a,b,c  

^a HÔPITAL BROUSSAIS   (France)

^b INSTITUT PASTEUR   (France)

^c Hopital Communautaire   (Central African Republic)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Africa; Breast milk; HIV 1; Immunoglobulin G; Mucosal immunity

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN G ANTIBODY; SYNTHETIC PEPTIDE;

ADULT; ANTIBODY RESPONSE; ARTICLE; BREAST MILK; CLINICAL ARTICLE; COLOSTRUM; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; MONOLAYER CULTURE; PRIORITY JOURNAL; SERUM; TRANSCYTOSIS;

ADOLESCENT; ADULT; ANIMALS; BREAST FEEDING; CELLS, CULTURED; COLOSTRUM; ENDOCYTOSIS; EPITOPES; FEMALE; HIV ANTIBODIES; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; MILK, HUMAN; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0032818767     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199907300-00008     Document Type: Article

References (67)

1. Van de Perre P, Simonon A, Msellati P, et aJ. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med 1991, 325:593-598.
2. Van de Perre P, Lepage P, Homsy J, Dabis F. Molher-lo-infant transmission of human immunodeficiency virus by breast milk: presumed innocent or presumed guilty? Clin Infect Dis 1992, 15:502-507.
3. Van de Perre P, Simonon A, Hitimana DC, et al. Infective and anti-infective properties of breast milk from human immunodeficiency virus type 1 infected mothers in relation to molher-to-child transmission. Lancet 1993, 341:914-918.
4. Van de Perre P. Postnatal transmission of the human immunodeficiency virus type 1 and the breast feeding dilemma. Am I Obstet Gynecol 1995, 173:483-487.
5. Van de Perre P, Cartoux M. Retroviral infection and breastfeeding. ; Clin Miaobiol Infect 1996, 1:6-12.
6. Becquart P, Carin B, Sepou A, et al. High incidence of early postnatal transmission of human immunodeficiency virus type 1 in Bangui, Central African Republic. J Infect Dis 1998, 177:1770-1771.
7. Dünn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding, tancet 1992, 340:585-588.
8. Leroy V, Newell ML, Dabis F, et aJ. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection, tancet 1998, 352:597-600.
9. Lewis P, Nduati R, Kreiss JK, et al. Cell-free human immunodeficiency virus type 1 in breast milk. ] Infect Dis 1998, 177:34-39.
10. Buranasin P, Kunakorn M, Petchclai B, et al. Detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in breast milk and colostrum of seropositive mothers. ] Med Assoc Thai 1993, 76:41-45.
11. Ruff A), Coberly J, Halsey NA, et al. Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors. I Acquir Immune DeficSyndr 1994, 7:68-73.
12. Nduati RVV, John CC, Richardson BA, et al. Human immunodeficiency virus type-1-infected cells in breast milk : association with immunosuppression and vitamin A deficiency. / Infect Dis 1995, 172:461-1468.
13. Swart PJ, Kuipers ME, Smit C, et al. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Res Hum Retroviruses 1996, 12:769-775.
14. Belec L, Bouquety JC, Georges AJ, Siopathis MR, Martin PMV. Antibodies to human immunodeficiency virus in the breast milk of healthy HIV-1 carrier women. Pediatrics 1990, 85: 022-1026.
15. Van de Perre P, Hitimana DC, Lepage P. Human immunodeficiency virus antibodies of IgG, IgA, and IgM subclasses in milk of seropositive mothers. J Pediatr 1988, 113:1039-1041.
16. Hocini H, Belec L, Iscaki S, et al. High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. AIDS Res Hum Retroviruses 1997, 13:1179-1185.
17. Goldman SS. The immune system of the human milk, antimicrobial, antiinflammatory and immunomodulating properties. Pediatr} Infect Dis 1993, 12:664-671.
18. Lamm ME. Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 1997, 51:311-340.
19. Renom C, Bouquety JC, Lanckriet C, Georges AJ, Siopthis MR, Martin PMV. HIV-specific IgA antibodies in tears of children with AIDS or at risk of AIDS. Res Virol 1990, 141:355-363.
20. O'Shea S, Cordery, M, Barrett WY, Richman DD, Bradbeer C, Banatvala JE. HIV excretion patterns and specific antibody responses in body fluids .J Med Virol 1990, 31:291-296.
21. Lu XS, Delfraissy JF, Grangeot-Keros L, Rannou MT, Pillot J. Rapid and constant detection of HIV antibody response in saliva of HIV infected patients; selective distribution of antiHIV activity in the IgG isotype. Res Viml 1994, 145:369-377.
22. Janoff EN, Jackson S, Wahl SM, Thomas K, Peterman JH, Smith PD. Intestinal mucosal immunoglobulins during human immunodeficiency virus lye 1 infection. I Infect Dis 1994, 170:299-307.
23. Wolff H, Mayer K, Seage G, Politch J, Horsburgh CR, Anderson D. Comparison of HIV-1 antibody classes, titres, and specificities in paired semen and blood samples from HIV-1 seropositive men.] Acquir Immune Defic Syndr 1992, 5:65-69.
24. Belec L, Georges A), Steenman G, Martin PMV. Antibodies to human immunodeficiency virus in tbe seminal fluid of heterosexual menj Infect Dis 1989, 159:324-327.
25. Belec L, Dupre T, Prazuck T, et aJ. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasting with normal or impaired local response in H1V infection. I Infect Dis 1995, 172:691-697.
26. Artenstein AW, VanCott TC, Sitz KV, et al. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1 : a comparison by site and correlation with clinical information. J Infect Dis 1997,175:265-271.
27. Haimovici F, Mayer KH, Anderson DJ. Quantitation of HIV-1 specific IgG, IgA, and IgM antibodies in human genital tract secretions. ] Acquir Immune Defic Syndr 1997, 15:185-191.
28. Smith PD. Mucosal immunopathophysiology of HIV infection. In Handbook of Mucosal Immunology. Edited by Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J. San Diego: Academic Press, Inc.; 1994:719-728.
29. Staats HF, McGhee JR. Mucosal immunity in HIV infection. In Immunology of HIV Infection. Edited by Gupta S. New York: Plenum Press; 1996:387-416.
30. Bienenstock J, Befus AD . Mucosal immunology. Immunology 1980,41:249-270.
31. McDermott MR, Befus AD, Bienenstock J. The structural basis for immunity in the respiratory tract. Int Rev Exp Pathol 1982, 23:47-112.
32. Berneman A, Belec L, Fischetti VA, Bouvet JP. The specific patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions. Infect Immunol 1998, 66:4163-4168.
33. Thiry L, Sprecher-Goldberger S, Jonckheer T, et al. Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers, lancet 1985, 2:891-892.
34. Vogt MW, Witt DJ, Craven DE, et al. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS, lancet 1986,i:525-527.
35. Belec L, Tévi-Bénissan C, Lu XS, Prazuck T, Pillot J. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection. AIDS Res Hum Relroviruses 1995, 11:719-729.
36. Belec L, Tévi-Bénissan C, Dupïé T, et al. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 categories) patients with HIV-1 and HIV-2 infection.; C//n Immunol 1996, 16:12-20.
37. Hocini H, Barra A, Belec L, et al. Specific and secretory humoral immunity in the normal human Cervicovaginal secretions. ScandJ Immunol 1995, 42:269-274.
38. Jonard PP, Rambaud JC, Dive C, Vaerman JP, Gallan A, Delacroix DL. Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A.] din Invest 1984, 74:525-535.
39. Burton DR, Montefiori DC. The antibody response in HIV-1 infection. AIDS 1997, 11 (suppl A):S87-S98.
40. Earl PL, Broder CC, Doms RW, Moss B. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein.; Viml 1997, 71:2674-2684.
41. Muster T, Steindl F, Purtscher, et al. A conserved neutralizing epilope on gp41 of human immunodeficiency virus type 1. I Viml 1993, 67:6642-6647.
42. Purtscher M, Trkola A, Grassauer A, et al. Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5. AIDS 1996, 10:587-593.
43. Pullen GR, Fitzgerald MC, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. I Immunol Methods 1986, 86:83-87.
44. Ball JM, Moldoveanu Z, Meisen LR, et al. A polarized human endomctrial cell line that binds and transports polymeric IgA. In vitro Cell Dev Biol 1995, 31:196-206.
45. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nature Med 1997, 3:2-47.
46. Phillips DM, Bourinbaiar AS. Mechanism of HIV spread from lymphocytes to epilhelia. Virology 1992, 186:261-273.
47. Brandtzaeg P. The secretory immune system of lactating human mammary glands compared with other exocrine organs. Ann NYAcadSci 1983, 409:353-381.
48. Brandtzaeg P. Distribution and characteristics of mucosal immunoglobulin-producing cells. In Handbook of Mucosal Immunology. Edited by Ogra P, Strober VV, Mestecky J, McChee JR, Lamm ME, Bienenstock, J. San Diego: Academic Press, Inc.; 1994:251-262.
49. Calarota S, Jansson M, Lev! M, et al. Immunodominant glycoprotein 41 epitope identified by seroreaclivity in HIV type 1infected individuals. AIDS Res Hum Retrow'ruses 1996, 12:705-713.
50. Bomsel M, Heyman M, Hocini H, et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dlgA or IgM. Immunity 1998, 9:277-287.
51. Toniolo A, Serra C, Conaldi PC, Basolo F, Falcone V, Dolei A. Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 1995, 9:859-866.
52. Hussain LA, Lehner T. Comparative investigation of Langerhans' cells and potential receptors for H1V in oral, genitourinary and rectal epithelia. Immunology 1995, 85:475-484.
53. Adachi A, Koenig S, Gendelman HE, et al. Productive persistent infection of human colorectal cell lines with human immunodeficiency virus.; Wro/1987, 61:209-213.
54. Fantini J, Yahi N, Tourres C, Delezay O, Tamalet C. HIV-1 transmission across the vaginal epithelium. AIDS 1997, 11:1663-1664.
55. Yahi N, Baghdiguian S, Morau H, Fantini J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells.; Virol 1992, 66:4848-4854.
56. Furuta Y, Eriksson K, Svennerholm B, et al. Infection of vaginal and colonie epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Nat/ AcadSdUSA 1994, 91:12559-12563.
57. Fox CH, Kotler D, Tierney A, Wilson CS, Fauci AS. Detection of IIIV-1 RNA in the lamina popria of patients with AIDS and gastrointestinal disease. ] Infect Dis 1989, 159:467-471.
58. Ullrich R, Zeitz M, Heise VV, L'Age M, Höffken G, Riecken EO. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for H1Vinduced enteropathy. Ann Intern Med 1989,111:15-21.
59. Jarry A, Cortez A, René E, Muzeau F, Brousse N. Infected cells and immune cells in the gastrointestinal tract of AIDS patients. An immunohistochemical study of 127 cases. Histopathohgy 1990, 16:133-140.
60. D'Souza MP, Livnat D, Bradac JA, Bridges S, AIDS Clinical Trials Group Antibody Selection Working Group and Collaborating Investigators. Evaluation of monoclonal antibodies to HIV-1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. S Infect Dis 1997, 175:1056-1062.
61. Bou-Habib DC, Roderiquez G, Oravecz T, Berman PW, Lusso P, Norcross MA. Cryptic nature of envelope V3 region epitopes protects primary human immunodeficiency virus type 1 from antibody neutralization. I Virol 1994, 68:6006-6013.
62. Moore JP, Cao Y, Qing L, et al. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. ] Wra/1995, 69:101-109.
63. Stamatatos L, Cheng-Mayer C. Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. ) Virol 1995, 69:6191-6198.
64. Poignard P, Klasse PJ, Sattentau QJ. Antibody neutralization of HIV-1. Immunol Today 1996, 17:239-246.
65. Wyatt R, Sodroski J. The HIV-1 envelope glycoproleins : fusogens, antigens, and immunogens. Science 1998, 280:1884-1888.
66. Trkola A, Pomales AP, Yuan H, et al. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-lgG. ] Virol 1995, 69:6609-6617.
67. Kaetzel CS, Robinson JK, Lamm ME. Epithelial transcytosis of monomeric IgA and IgG cross-linked through antigen to polymeric IgA. A role for monomeric antibodies in the mucosal immune system.I Immunol 1994, 152:72-76.